AlphaFold predicted structure
SPINT2 · O43291

Mean pLDDT
81.1/ 100
Confident
252 residues
Confidence breakdown
- Very high(≥ 90)54%
- Confident(70–90)16%
- Low(50–70)23%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
serine peptidase inhibitor, Kunitz type 2
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Choanal atresia
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntestinal failure or congenital diarrhoea
BIALLELIC, autosomal or pseudoautosomalLimb disorders
BIALLELIC, autosomal or pseudoautosomalOcular coloboma
BIALLELIC, autosomal or pseudoautosomalStructural eye disease
BIALLELIC, autosomal or pseudoautosomalcongenital sodium diarrhea
syndromic congenital sodium diarrhea
prostate carcinoma
abdominal abscess
digestive system disorder
hereditary disease
polydactyly
prostate cancer
non-small cell lung carcinoma
glioblastoma
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Kunitz-type protease inhibitor 2
Inhibitor of HGFAC (PubMed:9346890). Also inhibits plasmin, and plasma and tissue kallikrein (PubMed:9115294). Inhibits serine protease activity of TMPRSS13 (PubMed:20977675, PubMed:28710277). Inhibits serine protease activity of ST14/matriptase and PRSS8/prostasin in vitro (PubMed:28710277, PubMed:30445423)
SPINT2 · O43291

Mean pLDDT
81.1/ 100
Confident
252 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0